HOME >> BIOLOGY >> NEWS
Study Suggests Vaccine Increases Survival In Ovarian And Breast Cancer Patients Following High-Dose Chemotherapy And Autologous Stem Cell Transplant

A new study suggests that the administration of an experimental cancer vaccine following autologous stem cell transplant can increase survival and decrease relapse in ovarian and breast cancer patients when compared to the stem cell transplant procedure alone. The data was presented today at the 35th annual meeting of the American Society of Clinical Oncology (ASCO) in Atlanta, May 15-18, 1999.

The research team at the Fred Hutchinson Cancer Research Center, led by Leona Holmberg, M.D., Ph.D., and Brenda Sandmaier, M.D., treated 40 cancer patients (11 high-risk stage II/III breast, 22 stage IV breast and 7 stage III/IV ovarian) with high-dose chemotherapy followed by autologous/syngeneic stem cell transplantation. Twenty-six of the 40 patients also received five doses of THERATOPEO vaccine (STn-KLH), a therapeutic vaccine being developed by Biomira, Inc. of Alberta, Canada (NASDAQ: BIOM) (TSE, ME: BRA) that induces the body's immune system to mount a response against cancerous cells.

All patients were treated between Sept. 1, 1995 and Nov. 18, 1997. To gain preliminary evidence of the potential efficacy of the THERATOPE vaccine, the outcome of vaccinated patients was retrospectively compared to the outcome of patients not vaccinated.

Investigators found that the chance of death was more than 2 times greater among patients in the control group compared to patients vaccinated with THERATOPEO vaccine. The chance of relapse was approximately 1.7 times greater for patients in the control group compared to those vaccinated. In addition, those vaccinated patients with the highest amount of specific killing activity against STn-bearing cancer cells appeared to remain the longest in remission.

According to Dr. Holmberg, M.D., Ph.D., THERATOPEO vaccine was well tolerated after autologous stem cell transplant and in preliminary data may have improved outcomes. These results need to be considered within the debate over hematopoietic stem cell transpl
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
15-May-1999


Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... ... ... Keck Graduate Institute (KGI) President Sheldon Schuster has announced Martin Zdanowicz as the ... is highly regarded as an innovative leader who prioritizes student success and faculty development,” ... build on the success of the KGI School of Pharmacy and Health Sciences.” , ...
(Date:8/1/2019)... ... August 01, 2019 , ... The GENSPEED platform is a compact, fast and ... fully developed with over 100 units deployed in the field for multiple applications. ... collaboration with axiVEND will give us a foothold in the USA to better support ...
(Date:8/1/2019)... ... 2019 , ... USDM Life Sciences (USDM) announces that Jay Crowley, Vice President ... addressing challenges with the upcoming EU MDR IVDR regulations . , ... variety of positions over his 26 years at the FDA, including developing the framework ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/12/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... June ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... partnership agreement with Shanghai Zillion has been signed. The agreement will grant exclusive ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for ... will educate viewers about how its technology facilitates laboratories to improve efficiency and ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the ... national leader in opioid treatment, announced today they are partnering to combat the ... recently deployed its virtual care platform at the Mayo Clinic to drive shared ...
Breaking Biology Technology:
Cached News: